<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib65">
 <label>65</label>
 <element-citation publication-type="journal" id="sref65">
  <person-group person-group-type="author">
   <name>
    <surname>Jasenosky</surname>
    <given-names>L.D.</given-names>
   </name>
   <name>
    <surname>Cadena</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Mire</surname>
    <given-names>C.E.</given-names>
   </name>
   <name>
    <surname>Borisevich</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Haridas</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Ranjbar</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>The FDA-approved oral drug nitazoxanide amplifies host antiviral responses and inhibits Ebola virus</article-title>
  <source>iScience</source>
  <volume>19</volume>
  <year>2019</year>
  <fpage>1279</fpage>
  <lpage>1290</lpage>
  <pub-id pub-id-type="pmid">31402258</pub-id>
 </element-citation>
</ref>
